ARTICLE | Company News
Amarantus BioScience, UMMS deal
January 6, 2014 8:00 AM UTC
On Dec. 18, 2013, the medical school granted Amarantus an exclusive, worldwide license to IP covering the use of mesencephalic astrocyte-derived neurotrophic factor (MANF; ARP; ARMET) as a biomarker ...